03:21 PM EDT, 08/14/2024 (MT Newswires) -- CorMedix ( CRMD ) shares rose 29% in recent Wednesday trading after the company reported Q2 results.

The company posted a net loss of $0.25 per diluted share, compared with the loss of $0.25 a year earlier.

Four analysts polled by Capital IQ expected a loss of $0.25.

Revenue in the quarter ended June 30 was $806,119 with no revenue a year earlier.

Four analysts surveyed by Capital IQ expected $1.67 million.

Intraday trading topped 2.41 million shares versus the daily average of about 489,000

Price: 4.87, Change: +1.09, Percent Change: +28.70